Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar
Open accessThe DOI matches its Crossref record; 74 of the 76 references it cites were found in a registry or an index; 6 of the 70 sources its claims cite were checked for support.
Abstract
Between October 2001 and April 2002, five cases of acute flaccid paralysis (AFP) associated with type 2 vaccine-derived polioviruses (VDPVs) were reported in the southern province of the Republic of Madagascar. To determine viral factors that favor the emergence of these pathogenic VDPVs, we analyzed in detail their genomic and phenotypic characteristics and compared them with co-circulating enteroviruses. These VDPVs appeared to belong to two independent recombinant lineages with sequences from the type 2 strain of the oral poliovaccine (OPV) in the 5'-half of the genome and sequences derived from unidentified species C enteroviruses (HEV-C) in the 3'-half. VDPV strains showed characteristics similar to those of wild neurovirulent viruses including neurovirulence in poliovirus-receptor transgenic mice. We looked for other VDPVs and for circulating enteroviruses in 316 stools collected from healthy children living in the small area where most of the AFP cases occurred. We found vaccine PVs, two VDPVs similar to those found in AFP cases, some echoviruses, and above all, many serotypes of coxsackie A viruses belonging to HEV-C, with substantial genetic diversity. Several coxsackie viruses A17 and A13 carried nucleotide sequences closely related to the 2C and the 3D(pol) coding regions of the VDPVs, respectively. There was also evidence of multiple genetic recombination events among the HEV-C resulting in numerous recombinant genotypes. This indicates that co-circulation of HEV-C and OPV strains is associated with evolution by recombination, resulting in unexpectedly extensive viral diversity in small human populations in some tropical regions. This probably contributed to the emergence of recombinant VDPVs. These findings give further insight into viral ecosystems and the evolutionary processes that shape viral biodiversity.
Overview
CoChat Summary
## TL;DR
Madagascar’s Tolagnaro district had two independently emerging type 2 vaccine-derived poliovirus (VDPV) lineages associated with five AFP cases from October 2001 to April 2002, and these viruses showed recombination with unidentified species C enteroviruses (HEV-C). In 316 stool samples from healthy children, the authors found continued circulation of similar VDPVs plus unusually high HEV-C diversity and many recombination events, suggesting a local viral ecosystem that favors poliovirus evolution.
## Key findings
- Five AFP cases were associated with type 2 VDPVs reported between October 2001 and April 2002; genome sequencing showed the isolates fell into two independent recombinant lineages: one centered on MAD 04 (with MAD 05–07) and one on MAD 29.
- The Madagascan VDPVs had Sabin 2-like 5′ halves and diverged 3′ halves derived from non-vaccine sequences; the inferred recombination sites were near nt 3,801 for MAD 04 and related strains and near nt 3,708 for MAD 29.
- In 316 stool specimens from healthy children, the study isolated 23 PVs and 71 other viruses; 68 non-polio viruses were identified as enteroviruses, and the authors found 64 enteroviruses by VP1 typing, including 51 HEV-C isolates: 12 CA11, 16 CA13, 8 CA17, 1 CA20, and 14 CA24.
- The authors inferred 19 HEV-C recombinant lineages from incongruences among phylogenetic trees; they also found that two VDPVs from healthy children clustered with the MAD 04/MAD 07 lineage, and they note that only 7% of children were excreting Sabin-like PVs two weeks after the second local vaccination round.
## Methods
- The study combined outbreak investigation and field sampling in the Tolagnaro district: stool samples from AFP cases and 316 stool specimens from healthy children collected during June 21–22 field investigations.
- Viruses were isolated in RD, HEp-2c, and L20B cells, then characterized by RT-PCR, full-genome or partial sequencing, molecular typing, restriction analysis, and neutralization assays.
- Genetic relationships were assessed with alignment and phylogenetic analysis of VP1, 2C, 3D, and 5′ UTR sequences using maximum likelihood and neighbor-joining approaches; phenotypes were tested for temperature sensitivity, plaque size, antigenic structure, and neurovirulence in PVR-Tg mice.
## Limitations
- The paper states that search for viral mixtures was not the primary goal, and the viral isolation procedures were poorly adapted to detect them; it also notes that about 25% of PV-positive samples may have contained another enterovirus serotype masked on L20B cells.
- The authors note that re-inoculation of cells with neutralizing antibodies was not performed to check for a second serotype in positive samples.
- Evident from the text: the field sample was limited to one district and 316 children, so the findings describe a localized ecosystem rather than broader prevalence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Phylogenetic Trees Depicting Genetic Relationships between Nucleotide Sequences of Enteroviruses of the HEV-C Species These neighbor-joining trees were based on nucleotide sequence alignments of part of the 5′ UTR, the C-terminal third of the VP1-coding regions, part of the 2C-coding regions, and of the 3Dpol regions. Branch lengths were calculated using PUZZLE and the Hasegawa, Kishino, and Yano (HKY) model of substitution [63]. The genetic distance is indicated (bar). Numbers at nodes correspond to the percentage of 25,000 puzzle steps supporting the distal cluster; numbers in italics representing the percentage of 1,000 bootstrap pseudoreplicates obtained with the DNADist/Neighbor and SEQBOOT programs of PHYLIP [65] are shown in several cases. Sequences of some of the last wild PV strains (PV3.Mad95, PV1.Mad96a, PV1.Mad96b, and PV3.Mad97) isolated in Madagascar (1995–1997) were used in addition to HEV-C prototype strains (CA1 to CA24). Selected PV strains isolated during the last poliomyelitis outbreak in Finland (PV3.Fin84) and during the recent VDPV outbreaks in Egypt (PV2.Egy93; PV2.Egy88), Haiti (PV1.Hai00), Dominican Republic (PV1.Dor00), and the Philippines (PV1.Phi01) are included. Sequences of the recombinant type 3 PV isolated from a poliomyelitis case in Cambodia in 2002 (PV3.Cam02) were also used. Nucleotide sequences of echovirus 70 (EV70) were used as outgroup. Identifiers of the HEV-C coxsackie A viruses isolated from healthy children in 2002 in Madagascar consist of the given serotype as assessed from partial sequencing [33] and the laboratory number. New VDPV isolates from healthy children are indicated with their laboratory numbers. Spots of different colors differentiate HEV-C serotypes and polioviruses (red). VDPVs from Madagascar are indicated by oblong spots. According to the Eight Report of the ICTV [56], former CA15 and CA18 are considered as antigenic variants of CA11 and CA13, and are now named CA11v and CA13v, respectively. All field isolates from Madagascar, except isolates CA24.65902 and CA24.68187, were sequenced in the four regions. Vertical dotted lines indicate groups of isolates of particular interest that are discussed in the text.](https://figures.cochat.ai/paper-figures/a17253f9018b477283b49e5c4d249ecf/co-circulation-and-evolution-of-polioviruses-and-species-c-enteroviruses-in-a-figure-4.jpg)
Verification
Claims the paper makes
4 Valid · 0 Not valid · 27 Not checked · 101 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Between October 2001 and April 2002, five cases of acute flaccid paralysis (AFP) associated with type 2 vaccine-derived polioviruses (VDPVs) were reported in the southern province of the Republic of Madagascar.”
- Also stated in: § Introduction · plain
“In Madagascar, type 2 recombinant VDPVs were identified as the causative agent of five cases of poliomyelitis that occurred from October 2001 to April 2002 [14].”
§ Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar > Abstract Between October 2001 and April 2002, five cases of acute flaccid paralysis (AFP) associated with type 2 vaccine-derived polioviruses (VDPVs) were reported in the southern province of the Republic of Madagascar. To determine viral factors that favor the emergence of these pathogenic VDPVs, we analyzed in detail their genomic and phenotypic characteristics and compared them with co-circulating enteroviruses. These VDPVs appeared to belong to two independent recombinant lineages with sequences from the type 2 strain of the oral poliovaccine (OPV) in the 5′-half of the genome and sequences derived from unidentified species C enteroviruses (HEV-C) in the 3′-half. VDPV strains showed characteristics similar to those of wild neurovirulent viruses including neurovirulence in poliovirus-receptor transgenic mice. We looked for other VDPVs and for circulating enteroviruses in 316 stools collected from healthy children living in the small area where most of the AFP cases occurred. We found vaccine PVs, two VDPVs similar to those found in AFP cases, some echoviruses, and above all, many serotypes of coxsackie A viruses belonging to HEV-C, with substantial genetic diversity. Several coxsackie viruses A17 and A13 carried nucleotide sequences closely related to the 2C and the 3Dpol coding regions of the VDPVs, respectively. There was also evidence of multiple genetic recombination events among the HEV-C resulting in numerous recombinant genotypes. This indicates that co-circulation of HEV-C and OPV strains is associated with evolution by recombination, resulting in unexpectedly extensive viral diversity in small human populations in some tropical regions. This probably contributed to the emergence of recombinant VDPVs. These findings give further insight into viral ecosystems and the evolutionary processes that shape viral biodiversity.
What the sources say
- Supportedcites [14] 2003, Recombinant vaccine-derived poliovirus in Madagascar., Emerg Infect Dis source
The opening paragraph of “Recombinant Vaccine–Derived Poliovirus in Madagascar” states the same dates, number of acute flaccid paralysis cases, type 2 vaccine-derived poliovirus association, and location as the citing sentence. (LLM, conf=0.95)
plainstates an associationn = 5- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“In particular, from the analysis of similar recombinant type 2 VDPVs circulating in Egypt, the evolution rate of the capsid VP1 region appeared to be 2.5 (± 0.7).10−2 substitutions per synonymous site and per year [18].”
§ Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar > Results > Sequence Analysis of the Madagascan VDPV Genomes
What the sources say
- Supportedcites [18] 2003, Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993., J Virol source
The RESULTS section ('Estimated time of occurrence of initiating OPV dose', p. ~7) states the VP1 evolution rate from the regression slope as (2.47 ± 0.69) × 10−2 substitutions per synonymous site per year, which the citing sentence rounds to 2.5 (± 0.7) × 10−2. The same passage ties this to the Egyptian type 2 cVDPV isolates (1988–1993), and the Abstract/DISCUSSION confirm these isolates are recombinants with other species C enteroviruses, matching 'similar recombinant type 2 VDPVs circulating in Egypt'. (LLM, conf=0.95)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Most VDPV strains described as OPV/HEV-C recombinants were isolated in countries in which wild PVs have been eradicated”
§ Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar > Discussion
What the sources say
- Not checked yetcites [11] 2004, Circulating vaccine-derived polioviruses: current state of knowledge., Bull World Health Organ
- Not checked yetcites [12] 2002, Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus., Science source
- Partly supportedcites [14] 2003, Recombinant vaccine-derived poliovirus in Madagascar., Emerg Infect Dis sourceExperimental — accuracy not yet measured
The paper reports OPV/cluster C recombinant VDPVs in Madagascar and says no wild poliovirus strains had been isolated there since 1997 (main text; page unavailable). It also mentions similar recombinants in Hispaniola and the Philippines, but does not establish that wild poliovirus had been eradicated in those countries or that most such strains came from countries where it had been eradicated. (LLM, conf=0.82)
- Not checked yetcites [15] 2004, Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001., J Virol source
- Not checked yetcites [16] WHO, 2006, Vaccine-derived polioviruses: update., Wkly Epidemiol Rec
- Partly supportedcites [18] 2003, Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993., J Virol sourceExperimental — accuracy not yet measured
The Discussion says all outbreak-associated cVDPV isolates described at the time were recombinants with species C enteroviruses, and it links cVDPV emergence to elimination of competing wild polioviruses. But the claim overstates the eradication point: the paper describes elimination of the corresponding wild-poliovirus serotype, not all wild polioviruses in those countries; it says wild types 1 and 3 continued circulating in Egypt. (LLM, conf=0.88)
- Not checked yetcites [20] WHO, 2001, Transmission of wild poliovirus type 2-apparent global interruption., Wkly Epidemiol Rec
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“According to the sequence alignments presented in Figure 2, the likely sites of recombination in the genome of MAD 04 and other VDPV strains isolated in 2002 (MAD 05 to MAD 07) were all close to nt 3,801 (codon 139 of 2A).”
§ Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar > Results > Sequence Analysis of the Madagascan VDPV Genomes
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These VDPVs appeared to belong to two independent recombinant lineages with sequences from the type 2 strain of the oral poliovaccine (OPV) in the 5′-half of the genome and sequences derived from unidentified species C enteroviruses (HEV-C) in the 3′-half.”
§ Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar > Abstract Between October 2001 and April 2002, five cases of acute flaccid paralysis (AFP) associated with type 2 vaccine-derived polioviruses (VDPVs) were reported in the southern province of the Republic of Madagascar. To determine viral factors that favor the emergence of these pathogenic VDPVs, we analyzed in detail their genomic and phenotypic characteristics and compared them with co-circulating enteroviruses. These VDPVs appeared to belong to two independent recombinant lineages with sequences from the type 2 strain of the oral poliovaccine (OPV) in the 5′-half of the genome and sequences derived from unidentified species C enteroviruses (HEV-C) in the 3′-half. VDPV strains showed characteristics similar to those of wild neurovirulent viruses including neurovirulence in poliovirus-receptor transgenic mice. We looked for other VDPVs and for circulating enteroviruses in 316 stools collected from healthy children living in the small area where most of the AFP cases occurred. We found vaccine PVs, two VDPVs similar to those found in AFP cases, some echoviruses, and above all, many serotypes of coxsackie A viruses belonging to HEV-C, with substantial genetic diversity. Several coxsackie viruses A17 and A13 carried nucleotide sequences closely related to the 2C and the 3Dpol coding regions of the VDPVs, respectively. There was also evidence of multiple genetic recombination events among the HEV-C resulting in numerous recombinant genotypes. This indicates that co-circulation of HEV-C and OPV strains is associated with evolution by recombination, resulting in unexpectedly extensive viral diversity in small human populations in some tropical regions. This probably contributed to the emergence of recombinant VDPVs. These findings give further insight into viral ecosystems and the evolutionary processes that shape viral biodiversity.
hedgedn = 5- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
72 more claims
Create a free account to see all 132 claims and to verify the 64 references still open.
- Probably not a substantial claim. 22
- It may state two separate claims as one. 42
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The genomes of these VDPVs belong to several independent, complex mosaic recombinant lineages composed of sequences derived from vaccine polioviruses and other co-circulating species C human enteroviruses (human EV-C) (4,5).”
From Reemergence of Recombinant Vaccine–derived Polioviruses in Healthy Children, Madagascar (2013) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These VDPVs were found in patients with acute flaccid paralysis (AFP) and in healthy children who were contacts of the patients with AFP (2,4).”
From Reemergence of Recombinant Vaccine–derived Polioviruses in Healthy Children, Madagascar (2013) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“All recombinant cVDPV genomes described so far had kept at least the entire region encoding the capsid proteins of OPV strains (with more than 1% nt substitutions), and some or all of the rest of the genome, particularly the region encoding non-structural proteins, originates from other HEV-Cs [67,83,84,88–90].”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [88]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most of them showed the 3′-half of their genome derived from non-OPV sequences with recombination sites located in proteins 2A or 2B [67,83,84,88].”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [88]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most of the cVDPVs that have been described so far share phenotypic characteristics including the capacity to induce poliomyelitis in humans and in transgenic mice expressing CD155, the human cellular receptor for PV [67,83,84,88].”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [88]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617 · cited 2×
“A fragment of 299 to 322 bp corresponding to the 3 9 third of VP1 capsid was compared with the corresponding region of available prototype sequences, using the CLUSTAL W alignment program [59].”
MethodThompson, J. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.24.4876 · Cited by 38,993
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & MUENCH, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 19,926 · cited 2×
“Inoculated mice were monitored for 21 days and the PD50 was calculated by the method of Reed and Muench [ 68 ].”
MethodPHYLIP-Phylogeny inference package (Version 3.2)
Felsenstein, J. (1989) · Cladistics · Cited by 17,682
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227 · cited 1×
“The GenBank database was also screened for similar sequences using the FASTA program [60].”
MethodTree View: An application to display phylogenetic trees on personal computers
Page, R. D. M. (1996) · Bioinformatics · doi:10.1093/bioinformatics/12.4.357 · Cited by 10,178 · cited 1×
“Trees were drawn with the TREEVIEW [66] or NJ Plot programs [67].”
MethodDating of the human–ape splitting by a molecular clock of mitochondrial DNA.
Hasegawa, M., Kishino, H., & Yano, T.-A. (1985) · Journal of Molecular Evolution · doi:10.1007/bf02101694 · Cited by 8,687 · cited 1×
“The Hasegawa, Kishino, and Yano (HKY) model of substitution for nt with a Ts/Tv of 8.0 was used [64].”
MethodInfluentialLole, K. S., Bollinger, R. C., Paranjape, R. S., Gadkari, D., Kulkarni, S. S., Novak, N. G., Ingersoll, R., Sheppard, H. W., & Ray, S. C. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.152-160.1999 · Cited by 2,695 · cited 1×
“Complete genome sequences were compared following alignments with the plot-similarity program of GCG version 10.1 software (Genetics Computer Group, Madison, Wisconsin), using a 50-nt sliding window and the default scoring matrix [62].”
MethodInfluentialQuartet Puzzling: A Quartet Maximum-Likelihood Method for Reconstructing Tree Topologies
Strimmer, K., & von Haeseler, A. (1996) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a025664 · Cited by 2,531 · cited 1×
“regions. Branch lengths were calculated using PUZZLE and the Hasegawa, Kishino, and Yano (HKY) model of substitution [”
MethodWWW-query: An on-line retrieval system for biological sequence banks
Perrière, G., & Gouy, M. (1996) · Biochimie · doi:10.1016/0300-9084(96)84768-7 · Cited by 1,480 · cited 1×
“Trees were drawn with the TREEVIEW [66] or NJ Plot programs [67].”
MethodThree-Dimensional Structure of Poliovirus at 2.9 Å Resolution
Hogle, J. M., Chow, M., & Filman, D. J. (1985) · Science · doi:10.1126/science.2994218 · Cited by 1,260
Enteroviruses : Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses
Pallansch, M. (2001) · Medical Entomology and Zoology · Cited by 890
Oberste, M. S., Maher, K., Kilpatrick, D. R., & Pallansch, M. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1941-1948.1999 · Cited by 866 · cited 1×
“The nt sequences encoding the VP1 capsid protein of enterovirus isolates contain serotype-specific information [33–35].”
BackgroundVACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703 · cited 2×
“5 years, however, it could reach 10 years in Egypt [16,18,19].”
BackgroundSelf-citationKew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600 · cited 2×
“The first outbreak of poliomyelitis (21 cases) associated with VDPVs, was reported in 2000–2001, in the Dominican Republic and Haiti [12].”
BackgroundSelf-citationTyping of Human Enteroviruses by Partial Sequencing of VP1
Oberste, M. S., Maher, K., Kilpatrick, D. R., Flemister, M. R., Brown, B. A., & Pallansch, M. A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.5.1288-1293.1999 · Cited by 589 · cited 1×
“The nt sequences encoding the VP1 capsid protein of enterovirus isolates contain serotype-specific information [33–35].”
BackgroundStrebel, P. M., Sutter, R. W., Cochi, S. L., Biellik, R. J., Brink, E. W., Kew, O. M., Pallansch, M. A., Orenstein, W. A., & Hinman, A. R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.568 · Cited by 337 · cited 1×
“Nevertheless, the Sabin 2 strain also has the bad reputation of inducing the highest rate of VAPP following contact with vaccinees [9,42].”
BackgroundSelf-citationAntigenic Structure of Polioviruses of Serotypes 1, 2 and 3
Minor, P. D., Ferguson, M., Evans, D. M. A., Almond, J. W., & Icenogle, J. P. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-7-1283 · Cited by 305
Frequency and Dynamics of Recombination within Different Species of Human Enteroviruses
Simmonds, P., & Welch, J. (2006) · Journal of Virology · doi:10.1128/jvi.80.1.483-493.2006 · Cited by 269 · cited 1×
“Similar evolution processes, involving frequent intertypic recombination, have already been described mostly for HEV-B [46–52] and PVs [5,8,53,54].”
BackgroundOberste, M. S., Maher, K., & Pallansch, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.2.855-867.2004 · Cited by 260 · cited 1×
“Similar evolution processes, involving frequent intertypic recombination, have already been described mostly for HEV-B [46–52] and PVs [5,8,53,54].”
BackgroundCirculating vaccine-derived polioviruses: current state of knowledge.
Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N., & Pallansch, M. A. (2004) · PubMed · doi:10.1590/s0042-96862004000100006 · Cited by 258 · cited 1×
“The reversion of the OPV strains to neurovirulence is the underlying mechanism for the rare cases of vaccine-associated paralytic poliomyelitis (VAPP) among OPV recipients and their close contacts, and the occurrence of polio outbreaks associated with circulating vaccine-derived PV (VDPV) [10,11].”
BackgroundSelf-citationFine, P. E. M., & Carneiro, I. A. M. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009924 · Cited by 247 · cited 1×
“Previous immunisation responses may have limited subsequent multiplication and excretion of vaccine strains, and numbers of excretors [39].”
BackgroundVaccine-associated paralytic poliomyelitis. United States: 1973 through 1984
Nkowane, B. M. (1987) · JAMA · doi:10.1001/jama.257.10.1335 · Cited by 240 · cited 1×
“]. The reversion of the OPV strains to neurovirulence is the underlying mechanism for the rare cases of vaccine-associated paralytic poliomyelitis (VAPP) among OPV recipients and their close contacts, and the occurrence of polio outbreaks associated with circulating vaccine-derived PV (VDPV) [”
BackgroundBrown, B., Oberste, M. S., Maher, K., & Pallansch, M. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8973-8984.2003 · Cited by 238 · cited 3×
“[36] indicating that the 2C peptide sequences of prototypes CA17, CA11, and CA20 are particularly similar to those of PVs.”
BackgroundCirculation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H., Shimizu, H., Yoneyama, T., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8366-8377.2003 · Cited by 233 · cited 1×
“]. Prolonged circulation of type 2 VDPVs, responsible for 30 cases of AFP from 1983 to 1993, has been retrospectively demonstrated in Egypt [”
BackgroundSelf-citationThe molecular biology of poliovaccines
Minor, P. D. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-12-3065 · Cited by 217 · cited 1×
“PLoS Pathogens | www.plospathogens.org December 2007 | Volume 3 | Issue 12 | e191 replication cycle [ 3 ].”
Molecular strategy for ‘serotyping’ of human enteroviruses
Caro, V., Guillot, S., Delpeyroux, F., & Crainic, R. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-1-79 · Cited by 211 · cited 4×
“The serotype of the field isolates was assumed to be that of the closest prototype strain according to the results of pairwise comparisons of nt sequences, as previously described [33].”
BackgroundResultInfluentialSelf-citationNatural genetic exchanges between vaccine and wild poliovirus strains in humans.
Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert-Combiescu, A., Delpeyroux, F., & Crainic, R. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8434-8443.2000 · Cited by 202 · cited 6×
“Viral RNA was reverse transcribed as described previously either directly from viral stocks, following heat denaturation of the virions [8], or following viral RNA extraction [49].”
BackgroundMethodInfluentialSelf-citationRecombination in circulating enteroviruses
Lukashev, A. N., Lashkevich, V. A., Ivanova, O. E., Koroleva, G. A., Hinkkanen, A. E., & Ilonen, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10423-10431.2003 · Cited by 170 · cited 1×
“Similar evolution processes, involving frequent intertypic recombination, have already been described mostly for HEV-B [46–52] and PVs [5,8,53,54].”
BackgroundIdentification of two determinants that attenuate vaccine-related type 2 poliovirus
Ren, R. B., Moss, E. G., & Racaniello, V. R. (1991) · Journal of Virology · doi:10.1128/jvi.65.3.1377-1382.1991 · Cited by 163
Martín, J., Dunn, G., Hull, R., Patel, V., & Minor, P. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3001-3010.2000 · Cited by 160 · cited 1×
“The general molecular clock of PV has been estimated to be about 1% nt substitutions per year from studies on circulating strains and on viruses excreted from chronically infected immunodefi-cients [5,22–24].”
BackgroundCirculation of type 1 vaccine-derived poliovirus in the philippines in 2001
Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13512-13521.2004 · Cited by 146
Self-citationLindberg, A. M., Andersson, P., Savolainen, C., Mulders, M. N., & Hovi, T. (2003) · Journal of General Virology · doi:10.1099/vir.0.18971-0 · Cited by 143 · cited 1×
“Similar evolution processes, involving frequent intertypic recombination, have already been described mostly for HEV-B [46–52] and PVs [5,8,53,54].”
BackgroundGenetic basis of attenuation of the Sabin type-2 vaccine strain of poliovirus in primates.
Macadam, A. J., Pollard, S. R., Ferguson, G., Skuce, R., Wood, D., Almond, J. W., & Minor, P. D. (1993) · Virology · doi:10.1006/viro.1993.1003 · Cited by 139 · cited 1×
“antigenicity are labeled in bold [25,26,69–74].”
Recombinant Vaccine–Derived Poliovirus in Madagascar
Rousset, D., Rakoto-Andrianarivelo, M., Razafindratsimandresy, R., Randriamanalina, B., Guillot, S., Balanant, J., Mauclère, P., & Delpeyroux, F. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0907.020692 · Cited by 138 · cited 1×
“In Madagascar, type 2 recombinant VDPVs were identified as the causative agent of five cases of poliomyelitis that occurred from October 2001 to April 2002 [14].”
BackgroundSelf-citationGavrilin, G. V., Cherkasova, E. A., Lipskaya, G. Y., Kew, O. M., & Agol, V. I. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7381-7390.2000 · Cited by 138
Self-citationGenomic Features of Intertypic Recombinant Sabin Poliovirus Strains Excreted by Primary Vaccinees
Cuervo, N. S., Guillot, S., Romanenkova, N., Combiescu, M., Aubert-Combiescu, A., Seghier, M., Caro, V., Crainic, R., & Delpeyroux, F. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.5740-5751.2001 · Cited by 136
Self-citationBellmunt, A., May, G., Zell, R., Pring-Åkerblom, P., Verhagen, W., & Heim, A. (1999) · Virology · doi:10.1006/viro.1999.0003 · Cited by 128 · cited 1×
“The general molecular clock of PV has been estimated to be about 1% nt substitutions per year from studies on circulating strains and on viruses excreted from chronically infected immunodefi-cients [5,22–24].”
Background(1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.5.1097 · Cited by 126
Lentz, K. N., Smith, A. D., Geisler, S. C., Cox, S., Buontempo, P. J., Skelton, A., DeMartino, J., Rozhon, E. J., Schwartz, J. L., GIRIJAVALLABHAN, V. M., et al. (1997) · Structure · doi:10.1016/s0969-2126(97)00249-9 · Cited by 123
Comparative study of five methods for intratypic differentiation of polioviruses
van der Avoort, H. G., Hull, B. P., Hovi, T., Pallansch, M. A., Kew, O. M., Crainic, R., Wood, D. J., Mulders, M. N., & van Loon, A. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.10.2562-2566.1995 · Cited by 122
Self-citationGeorgescu, M. M., Delpeyroux, F., Tardy-Panit, M., Balanant, J., Combiescu, M., Combiescu, A. A., Guillot, S., & Crainic, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8089-8101.1994 · Cited by 109
Self-citationShulman, L. M., Manor, Y., Handsher, R., Delpeyroux, F., McDonough, M. J., Halmut, T., Silberstein, I., Alfandari, J., Quay, J., Fisher, T., et al. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.10.3729-3734.2000 · Cited by 109 · cited 2×
“PV strain S2/4568 has been described previously: it is a highly neurovirulent and non-temperature sensitive vaccine-derived strain, of serotype 2 [28].”
BackgroundMethodSelf-citationVaccine-Associated Paralytic Poliomyelitis
Beausoleil, J. L., Nordgren, R. E., & Modlin, J. F. (1994) · Journal of Child Neurology · doi:10.1177/088307389400900324 · Cited by 108
Jiang, P., Faase, J. A. J., Toyoda, H., Paul, A., Wimmer, E., & Gorbalenya, A. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700451104 · Cited by 105 · cited 2×
“These various considerations argue for a long-term evolution process involving wild or vaccine PVs and some HEV-C viruses (at least CA17 and CA13) and lend support to the proposal that PVs and HEV-C should be considered to be members of a single species [5,36,55,56].”
BackgroundMethodPipkin, P. A., Wood, D. J., Racaniello, V. R., & Minor, P. D. (1993) · Journal of Virological Methods · doi:10.1016/0166-0934(93)90022-j · Cited by 105
Macadam, A. I., Pollard, S., Ferguson, G. L., Dunn, G., Skuce, R., Almond, J. W., & Minor, P. D. (1991) · Virology · doi:10.1016/0042-6822(91)90877-e · Cited by 105
Natural genetic recombination between co-circulating heterotypic enteroviruses
Oprisan, G., Combiescu, M., Guillot, S., Caro, V., Combiescu, A., Delpeyroux, F., & Crainic, R. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-9-2193 · Cited by 105 · cited 1×
“Similar evolution processes, involving frequent intertypic recombination, have already been described mostly for HEV-B [46–52] and PVs [5,8,53,54].”
BackgroundSelf-citationLipskaya, G. Y., Muzychenko, A. R., Kutitova, O. K., Maslova, S. V., Equestre, M., Drozdov, S. G., Bercoff, R. P., & Agol, V. I. (1991) · Journal of Medical Virology · doi:10.1002/jmv.1890350415 · Cited by 97 · cited 2×
“Intertypic recombination is a frequent phenomenon in OPV vaccinees, and strains with a recombinant genome have been isolated from both healthy vaccinees and from patients with vaccine-associated polio-myelitis [6–9].”
BackgroundHorie, H., Koike, S., Kurata, T., Sato-Yoshida, Y., Ise, I., Ota, Y., Abe, S., Hioki, K., Kato, H., & Taya, C. (1994) · Journal of Virology · doi:10.1128/jvi.68.2.681-688.1994 · Cited by 96 · cited 2×
“We also evaluated the pathogenicity of the Madagascan VDPVs by IC and IP inoculation of groups of homozygous PVR-Tg21 mice [29] with a single virus dose per animal (Figure 3).”
MethodArita, M., Zhu, S.-L., Yoshida, H., Yoneyama, T., Miyamura, T., & Shimizu, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12650-12657.2005 · Cited by 95 · cited 4×
“Up to now only a Sabin3/HEV-C recombinant from Cambodia was shown to be directly related to indigenous CA17 strains in the 2BC genomic region and to a CA13 isolate in the 3D region [53].”
BackgroundInfluentialSerial Recombination during Circulation of Type 1 Wild-Vaccine Recombinant Polioviruses in China
Liu, H.-M., Zheng, D.-P., Zhang, L.-B., Oberste, M. S., Kew, O. M., & Pallansch, M. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.10994-11005.2003 · Cited by 88 · cited 3×
“These various considerations argue for a long-term evolution process involving wild or vaccine PVs and some HEV-C viruses (at least CA17 and CA13) and lend support to the proposal that PVs and HEV-C should be considered to be members of a single species [5,36,55,56].”
BackgroundSelf-citationAn Outbreak of Poliomyelitis Caused by Type 1 Vaccine‐Derived Poliovirus in China
Liang, X., Zhang, Y., Xu, W., Wen, N., Zuo, S., Lee, L. A., & Yu, J. (2006) · The Journal of Infectious Diseases · doi:10.1086/506359 · Cited by 87 · cited 1×
“Type 1 non-recombinant and vaccine/vaccine recombinant VDPVs have circulated for about one year in China and in Romania, respectively, showing that recombination with HEV-C is not essential for OPV strains to become circulating VDPVs [13,57].”
BackgroundChevaliez, S., Szendrôi, A., Caro, V., Balanant, J., Guillot, S., Berencsi, G., & Delpeyroux, F. (2004) · Virology · doi:10.1016/j.virol.2004.04.026 · Cited by 81 · cited 2×
“Viral RNA was reverse transcribed as described previously either directly from viral stocks, following heat denaturation of the virions [8], or following viral RNA extraction [49].”
MethodSelf-citationTripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus
Georgescu, M., Delpeyroux, F., & Crainic, R. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-9-2343 · Cited by 76 · cited 1×
“Similar evolution processes, involving frequent intertypic recombination, have already been described mostly for HEV-B [46–52] and PVs [5,8,53,54].”
BackgroundSelf-citationKorotkova, E. A., Park, R., Cherkasova, E. A., Lipskaya, G. Y., Chumakov, K. M., Feldman, E. V., Kew, O. M., & Agol, V. I. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12460-12465.2003 · Cited by 73 · cited 1×
“These characteristics, may explain why Sabin 2-derived viruses can in some circumstances, circulate in human populations and subsequently acquire pathogenic characteristics [43].”
BackgroundSelf-citationAgol, V. I. (2006) · Biologicals · doi:10.1016/j.biologicals.2006.02.007 · Cited by 71 · cited 4×
“In most cases, low vaccine coverage is thought to have allowed the circulation of OPV strains in non-vaccinated children and the subsequent genetic and phenotypic drift of these strains to pathogenic circulating VDPVs [ 16 ].”
BackgroundInfluentialIsolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child
Adu, F., Iber, J. C., Bukbuk, D. N., Gumede, N., Yang, S.-J., Jorba, J. C., Campagnoli, R. P., Sule, W. F., Yang, C.-F., Burns, C. C., et al. (2007) · Virus Research · doi:10.1016/j.virusres.2007.03.009 · Cited by 70 · cited 1×
“Very recently, numerous poliomyelitis cases due to different type 2 VDPV lineages were reported in Nigeria, a country still endemic for wild PVs [17,45].”
BackgroundSelf-citationYakovenko, M. L., Cherkasova, E. A., Rezapkin, G. V., Ivanova, O. E., Ap, I., Eremeeva, T. P., Baykova, O. Y., Chumakov, K. M., & Agol, V. I. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.2641-2653.2006 · Cited by 65 · cited 2×
“antigenicity are labeled in bold [25,26,69–74].”
Genetic recombination in wild-type poliovirus
Dahourou, G., Guillot, S., Le Gall, O., & Crainic, R. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-12-3103 · Cited by 63 · cited 1×
“In addition, recombination contributes to the variability of PV strains [4,5].”
BackgroundSelf-citationEmergence of recent echovirus 30 lineages is marked by serial genetic recombination events
Mirand, A., Henquell, C., Archimbaud, C., Peigue-Lafeuille, H., & Bailly, J.-L. (2007) · Journal of General Virology · doi:10.1099/vir.0.82146-0 · Cited by 59 · cited 1×
“Similar evolution processes, involving frequent intertypic recombination, have already been described mostly for HEV-B [46–52] and PVs [5,8,53,54].”
BackgroundHigh Frequency of Human Enterovirus Species C Circulation in Madagascar
Andrianarivelo, M. R., Rousset, D., Razafindratsimandresy, R., Chevaliez, S., Guillot, S., Balanant, J., & Delpeyroux, F. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.242-249.2005 · Cited by 56 · cited 12×
“Here, we describe two different lineages of type 2 PV/HEV-C recombinant VDPVs that appeared and circulated independently in Madagascar, and that induced paralytic polio-myelitis.”
BackgroundInfluentialSelf-citationMaldonado, Y., Peña‐Cruz, V., Sanchez, M. D. L. L., Logan, L., Blandon, S., Cantwell, M. F., Matsui, S. M., Millan-Velasco, F., Valdespino, J. L., & Sepúlveda, J. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.3.545 · Cited by 52 · cited 2×
“However, we cannot exclude the possibility that interference between OPV strains and the numerous endogenous enteroviruses circulating in the province, or some other host and environmental factors contributed to reducing vaccine strain multiplication and to limiting OPV immunogenicity [40,41].”
BackgroundCost analysis of post-polio certification immunization policies.
Sangrujee, N., Cáceres, V. M., & Cochi, S. L. (2004) · PubMed · Cited by 41
Laboratory surveillance for wild and vaccine-derived polioviruses, January 2002-June 2003.
(2003) · PubMed · Cited by 41
Transmission of wild poliovirus type 2--apparent global interruption.
(2001) · PubMed · Cited by 40
Progress toward interruption of wild poliovirus transmission--worldwide, January 2006-May 2007.
(2007) · PubMed · Cited by 38
Unimmunized Gypsy Populations and Implications for the Eradication of Poliomyelitis in Europe
Aylward, R. B., Porta, D., Fiore, L., Ridolfi, B., Chierchini, P., & Forastiere, F. (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.supplement_1.s86 · Cited by 30 · cited 1×
“Sabin 2 is highly immunogenic in vaccinees and induces higher seroconversion rates than do the other two OPV serotypes [38,40,41].”
BackgroundAntigenic Sites on Type 2 Poliovirus
Patel, V., Ferguson, M. A. J., & Minor, P. D. (1993) · Virology · doi:10.1006/viro.1993.1044 · Cited by 28 · cited 2×
“The antigenic properties of viruses were studied by a microneutralization assay as previously described [25,26] using PV Sabin-specific MAbs corresponding to antigenic sites 1 to 3.”
MethodResultCirculation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania
Combiescu, M., Guillot, S., Persu, A., Băicuş, A., Pițigoi, D., Balanant, J., Oprişan, G., Crainic, R., Delpeyroux, F., & Aubert-Combiescu, A. (2006) · Archives of Virology · doi:10.1007/s00705-006-0884-y · Cited by 19 · cited 1×
“Type 1 non-recombinant and vaccine/vaccine recombinant VDPVs have circulated for about one year in China and in Romania, respectively, showing that recombination with HEV-C is not essential for OPV strains to become circulating VDPVs [13,57].”
BackgroundSelf-citationRomanenkova, N. I., Guillot, S., Rozaeva, N. R., Crainic, R., Bichurina, M. A., & Delpeyroux, F. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00017-06 · Cited by 16 · cited 1×
“the genome (the VP3/VP1 capsid region and the 3D-39-UTR) and the restriction enzymes DpnII, DdeI, HinfI and RsaI as previously described [58].”
MethodSelf-citationGlobal update on vaccine-derived polioviruses, January 2006-August 2007.
(2007) · PubMed · Cited by 14
Vaccine-derived polioviruses--update.
(2006) · PubMed · Cited by 8
Laboratory surveillance for wild and vaccine-derived polioviruses, January 2004-June 2005.
(2005) · PubMed · Cited by 6
Research works printed but not linked: 2
- StanwayGBrownFChristianPHoviTHyypiäT 2005 Family Picornaviridae. In: FauquetCMMayoMAManiloffJDesselbergerUBallLA Virus taxonomy: eighth report of the international committee on taxonomy of viruses London Elsevier/Academic Press 757 778
- 1938, A simple method for estimating fifty percent endpoints., Amer J Hyg, 27, 493
Cited by
Combelas, N., Holmblat, B., Joffret, M.-L., Colbère-Garapin, F., & Delpeyroux, F. (2011) · Viruses · doi:10.3390/v3081460 · Cited by 135
“Most of them showed the 3'-half of their genome derived from non-OPV sequences with recombination sites located in proteins 2A or 2B [67,83,84,88].”
BackgroundSelf-citationYozwiak, N. L., Skewes-Cox, P., Gordon, A., SABORÍO, S. I., Kuan, G., Balmaseda, Á., Ganem, D., Harris, E., & DeRisi, J. L. (2010) · Journal of Virology · doi:10.1128/jvi.00698-10 · Cited by 144
Recombination in Enteroviruses, a Multi-Step Modular Evolutionary Process
Muslin, C., Kain, A. M., Bessaud, M., Blondel, B., & Delpeyroux, F. (2019) · Viruses · doi:10.3390/v11090859 · Cited by 142
“Thus, the multiplication and circulation of OPV strains in close interaction with other EV-Cs within a diverse EV ecosystem led to exchanges of genetic fragments through intertypic recombination and the emergence of these cVDPV strains [65,70,86].”
BackgroundInfluentialSelf-citationJegouic, S., Joffret, M.-L., Blanchard, C., Riquet, F. B., Perret, C., Pelletier, I., Colbere-Garapin, F., Rakoto-Andrianarivelo, M., & Delpeyroux, F. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000412 · Cited by 116
“The 2C sequences of a CA20 isolate from Tolagnaro were previously found to be related to those of MAD04 [27].”
BackgroundResultInfluentialSelf-citationHu, Y., Yang, F., Du, J., Dong, J., Zhang, T., Wú, Z., Xue, Y., & Jin, Q. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00007-11 · Cited by 119
“Ten outbreaks of poliomyelitis caused by pathogenic circulating vaccine-derived polioviruses (cVDPVs) have been reported so far, and most cVDPVs were recombinants of vaccine strains and other cocirculating HEV-C viruses, such as CVA13 and CVA17 (14, 36).”
Background
Metadata
- Authors
- Rakoto-Andrianarivelo, M., Guillot, S., Iber, J., Balanant, J., Blondel, B., Riquet, F., Martin, J., Kew, O., Randriamanalina, B., Razafinimpiasa, L., Rousset, D., & Delpeyroux, F.
- Affiliations
- Institut Pasteur (FR)
- Centers for Disease Control and Prevention (US)
- Centre Pasteur du Cameroun (CM)
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-12-14
- Volume
- 3
- Issue
- 12
- Pages
- e191
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2134956
- OpenAlex
- W2119910918
- Cited by
- 96
- References
- 76
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 5 · 2018: 4 · 2017: 3 · 2016: 9 · 2015: 7 · 2014: 6 · 2013: 7 · 2012: 11
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- vaccine-derived poliovirus, poliovirus type 2, co-circulation, viral recombination, acute flaccid paralysis, echovirus, neurovirulence, poliovirus evolution, viral diversity, Madagascar
- MeSH terms
- Animals, Cells, Cultured, Disease Outbreaks, Feces, Female, Humans, Madagascar, Male, Paralysis, Poliovirus Vaccine, Oral, Recombination, Genetic, RNA, Viral, Serotyping, Genome, Viral, Molecular Epidemiology, Poliovirus, Evolution, Molecular, Genomics, Enterovirus C, Human, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.